Recent strategies to improve boron dipyrromethene (BODIPY) for photodynamic cancer therapy: an updated review
BODIPYs are photosensitizers activatable by light to generate highly reactive singlet oxygen (1O2) from molecular oxygen, leading to tissue damage in the photoirradiated region. Despite their extraordinary photophysical characteristics, they are not featured in clinical photodynamic therapy. This re...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Published: |
Royal Society of Chemistry
2018
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/21576/ https://doi.org/10.1039/C8PP00113H |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | BODIPYs are photosensitizers activatable by light to generate highly reactive singlet oxygen (1O2) from molecular oxygen, leading to tissue damage in the photoirradiated region. Despite their extraordinary photophysical characteristics, they are not featured in clinical photodynamic therapy. This review discusses the recent advances in the design and/or modifications of BODIPYs since 2013, to improve their potential in photodynamic cancer therapy and related areas. |
---|